NCT02263911View on ClinicalTrials.gov

A Study of Baricitinib in Healthy Japanese Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Healthy Participants
Interventions
DRUG

Baricitinib

Administered orally

Trial Locations (1)

192-0071

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Hachiōji

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT02263911 - A Study of Baricitinib in Healthy Japanese Participants | Biotech Hunter | Biotech Hunter